Key facts
- It has raised $6.2M; the latest was Early Stage VC ($2.7M) in Jan 2026.
- Notable investors include Accel, Rainmatter Capital, Claypond Capital Partners, NKSquared, Nitin Kamath — 6 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 6 names
- ·Watchlist + deal alerts for Biopeak
- ·The full record, as it builds
Funding rounds
No funding rounds for Biopeak are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Biopeak
Operator of a personalized healthcare platform intended to enhance health and longevity through advanced diagnostics and wellness plans. The company offers a multiomics approach combined with artificial intelligence-driven insights, enabling individuals to optimize their health through personalized care, proactive prevention, and therapies, improving well-being, vitality, and long-term health outcomes.
- Sector
- Healthcare
- HQ
- Bengaluru, India
- Founded
- 2024
- Employees
- 24
- Website
- biopeak.com/
- Ownership
- Privately Held (backing)
Biopeak doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Biopeak shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Biopeak in its N-PORT filings yet. We sweep new filings monthly.